U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H23ClN6O2
Molecular Weight 450.921
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SUVOREXANT

SMILES

C[C@@H]1CCN(CCN1C(=O)C2=C(C=CC(C)=C2)N3N=CC=N3)C4=NC5=C(O4)C=CC(Cl)=C5

InChI

InChIKey=JYTNQNCOQXFQPK-MRXNPFEDSA-N
InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
SUVOREXANT
DASH   INN   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
BELSOMRA COMPONENT SUVOREXANT
Brand Name English
SUVOREXANT [JAN]
Common Name English
METHANONE, ((7R)-4-(5-CHLORO-2-BENZOXAZOLYL)HEXAHYDRO-7-METHYL-1H-1,4-DIAZEPIN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)-
Systematic Name English
MK4305
Code English
SUVOREXANT [USAN]
Common Name English
suvorexant [INN]
Common Name English
MK-4305
Code English
SUVOREXANT [MI]
Common Name English
Suvorexant [WHO-DD]
Common Name English
SUVOREXANT COMPONENT OF BELSOMRA
Brand Name English
((7R)-4-(5-CHLORO-1,3-BENZOXAZOL-2-YL)-7-METHYL-1,4-DIAZEPAN-1-YL)(5-METHYL-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE
Systematic Name English
SUVOREXANT [ORANGE BOOK]
Common Name English
BELSOMRA
Brand Name English
SUVOREXANT [VANDF]
Common Name English
Classification Tree Code System Code
WHO-ATC N05CM19
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
DEA NO. 2223
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
NDF-RT N0000191000
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
Code System Code Type Description
EVMPD
SUB180101
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
EPA CompTox
DTXSID90145616
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
IUPHAR
2890
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
ChEMBL
CHEMBL1083659
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
NDF-RT
N0000185503
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY P-Glycoprotein Inhibitors [MoA]
RXCUI
1547099
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY RxNorm
NDF-RT
N0000190114
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY Cytochrome P450 3A Inhibitors [MoA]
FDA UNII
081L192FO9
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
CAS
1030377-33-3
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
INN
9435
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
SMS_ID
100000166111
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
CHEBI
82698
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
NDF-RT
N0000190998
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY Orexin Receptor Antagonists [MoA]
NCI_THESAURUS
C171858
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
USAN
XX-119
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
PUBCHEM
24965990
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
MERCK INDEX
m11766
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
DRUG BANK
DB09034
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
DAILYMED
081L192FO9
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
DRUG CENTRAL
4881
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
WIKIPEDIA
SUVOREXANT
Created by admin on Fri Dec 15 16:07:42 UTC 2023 , Edited by admin on Fri Dec 15 16:07:42 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of SUVOREXANT
SALT/SOLVATE (PARENT)
Structure of SUVOREXANT HYDROCHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966